Celtaxsys cystic fibrosis drug reduces key symptom in mid-stage study
August 02, 2018 at 08:00 AM EDT
Privately held Celtaxsys Inc said on Thursday a mid-stage trial testing its experimental cystic fibrosis treatment was successful in reducing a key symptom of the genetic lung disease, but did not improve lung function.